Key result
Nemaline myopathy is linked to cardiac complications in ~16% of patients across lifespans.
Why the study?
Nemaline myopathy is prevalent and morbid but underrepresented in studies of lived experience and impact on patients and caregivers.
What are the daily challenges, medical complications, and priorities for future treatment development reported by patients with Nemaline Myopathy and their caregivers?
Cross-Sectional
Yes
What are the daily challenges, medical complications, and priorities for future treatment development reported by patients with Nemaline Myopathy and their caregivers?
This multinational survey highlights significant daily challenges and a notable prevalence of cardiac complications in patients with Nemaline Myopathy, emphasizing the need for patient-centered therapeutic development.
Patient-caregiver perspectives in NM highlight care gaps across ages; hypothesis-generating and should not yet change practice.
Nemaline myopathy (NM) is among the most common of the congenital myopathies, characterized by hypotonia and muscle weakness. Despite its prevalence and morbidity, NM remains underrepresented in studies of lived experience and the impact on patients and caregivers. To expand upon the current knowledge, we conducted an international cross-sectional survey to systematically characterize patient and caregiver perspectives, including daily challenges, medical complications across age groups, and priorities for future treatment development. All respondents reported facing daily challenges, regardless of disease severity. The most frequently cited challenges related to NM included mobility, fatigue, respiratory, and mental health. Our results indicated that children more frequently were reported as having severe phenotypes, and adults often present with milder forms, likely due to survival bias. While 7% of participants reported congenital-onset cardiac complications, 16% reported cardiac complications developing during childhood or adulthood. This study provides the first comprehensive assessment of NM patient and caregiver perspectives across age groups, severity levels, and 33 countries. By uncovering previously unreported insights, these findings establish a more complete understanding of NM that strengthens the patient-centered translational impact for future study and therapeutic development.
No takes yet. Share an insight, caveat, or question.
Cossette et al. (2026) conducted a cross-sectional in Nemaline myopathy. Nemaline myopathy was evaluated on Daily challenges and medical complications. A multinational survey of nemaline myopathy patients and caregivers revealed that 100% face daily challenges, with 16% developing cardiac complications during childhood or adulthood.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: